ABBV
AbbVie
NYSE • USD
$227.26
Loading chart…Fetching market history.
About AbbVie
AbbVie, headquartered in North Chicago, Illinois, develops and delivers a broad portfolio of medicines addressing chronic and complex diseases. Its products include leading treatments in immunology and neuroscience, as well as a growing pipeline in oncology and eye care. The company expands its capabilities through strategic acquisitions and partnerships, strengthening its research and development across multiple therapeutic areas while maintaining a global commercial presence.


